Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Lower SHBG levels may increase the risk of PCOS.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

New treatments for male hypogonadism are effective and should be personalized.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Obese women with PCOS are more likely to have fatty liver disease.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.